Summary of the effect on breastfeeding
IrbesartanLast Revision: January 20, 2020. CASRN: 138402-11-6 Drug Levels and EffectsSummary of Use during LactationBecause no information is available on the use of irbesartan during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Drug LevelsMaternal Levels. Relevant published information was not found as of the revision date. Infant Levels. Relevant published information was not found as of the revision date. Effects on Lactation and BreastmilkRelevant published information was not found as of the revision date. Alternate Drugs to ConsiderSubstance IdentificationSubstance NameIrbesartan CAS Registry Number138402-11-6 Drug ClassBreast Feeding Antihypertensive Agents Angiotensin II Type 1 Receptor Blockers Angiotensin Receptor Blockers ARBs
|